# FDA Inspection 1250807 - Covis Pharma GmBH - September 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/9d7b8cb0-e107-4ecb-bc9d-dba336151f37
Source feed: FDA_Inspections

> FDA Inspection 1250807 for Covis Pharma GmBH on September 19, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250807
- Company Name: Covis Pharma GmBH
- Inspection Date: 2024-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1250807 - 2024-09-19](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/8f50ef65-8fa0-4031-ab2d-117c80dc0f71)
- [FDA Inspection 1087302 - 2019-04-05](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/db0b80c1-3aa9-41a8-86a7-3ee7ad3c3e1a)
- [FDA Inspection 1071326 - 2018-10-22](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/1514e60a-422a-41a1-8625-2dddda6560dd)
- [FDA Inspection 981007 - 2016-07-15](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/e03436c5-2531-4b26-94ec-738dabe9dd52)
- [FDA Inspection 892953 - 2014-07-28](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/88fb2b99-8685-4234-b6dc-1010f35b4c7d)

Company: https://www.keypedia.com/companies/covis-pharma-gmbh/d1616a5d-a379-4021-b5aa-ef8f369c9a92

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c